Home
Resources
Publications
The Competitive NMDA Receptor Antagonists CGP 37849 and CGP 39551 Are Potent, Orally-Active Anticonvulsants in Rodents

The Competitive NMDA Receptor Antagonists CGP 37849 and CGP 39551 Are Potent, Orally-Active Anticonvulsants in Rodents

M Schmutz, C Portet, A Jeker, K Klebs, A Vassout, H Allgeier, R Heckendorn, G E Fagg, H R Olpe, H van Riezen

Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):61-6.

PMID: 1976233

Abstract:

Anticonvulsant properties of CGP 37849 and CGP 39551, two novel phosphono-amino acids which are competitive NMDA receptor antagonists, were examined in rodents. At optimal pretreatment times CGP 37849 suppressed electroshock-induced seizures in mice and rats with ED50s ranging from 8 to 22 mg/kg after oral administration, and 0.4 to 2.4 mg/kg after i.v. and i.p. injection. Relative to CGP 37849, CGP 39551 was more potent after p.o. (ED50 3.7-8.1 mg/kg), and less potent after i.v. or i.p. treatment (ED50 2.7-8.7 mg/kg). Following oral treatment, the duration of action of CGP 37849 was about 8 h, while CGP 39551 still showed good activity after 24 h (ED50 8.7 mg/kg, mouse; 21 mg/kg, rat). Both compounds were anticonvulsant at doses below those at which overt behavioural side effects were apparent. CGP 39551 delayed the development of kindling in rats at doses of 10 mg/kg p.o. and above, and showed weak anticonvulsant activity against pentylenetetrazol-evoked seizures. CGP 37849 and CGP 39551 are the first competitive NMDA antagonists to show oral anti-convulsant properties in a therapeutically-useful dose-range, and hence are interesting candidates for novel antiepileptic therapy in man.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP127910321	CGP 39551		127910-32-1	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: